PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP) MIMICS THE ACTIONS OF VASOACTIVE-INTESTINAL-PEPTIDE (VIP) ON GASTRIC CHIEF CELLS

被引：0

作者：

RAUFMAN, JP ^{[1
]}

SINGH, L ^{[1
]}

机构：

[1] SUNY HLTH SCI CTR,DEPT MED,BROOKLYN,NY

来源：

CLINICAL RESEARCH | 1992年 / 40卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：A262 / A262

页数：1

共 50 条

[31] Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide as modulators of innate and adaptive immunity
Delgado, M
EXPERIMENTAL DERMATOLOGY, 2004, 13 (09) : 573 - 573
[32] Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on hormone secretion from sheep pituitary cells in vitro
Sawangjaroen, K
Anderson, ST
Curlewis, JD
JOURNAL OF NEUROENDOCRINOLOGY, 1997, 9 (04) : 279 - 286
[33] Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: Players in innate and adaptive immunity
Ganea, D
Rodriguez, R
Delgado, M
CELLULAR AND MOLECULAR BIOLOGY, 2003, 49 (02) : 127 - 142
[34] Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex
Zawilska, JB
Niewiadomski, P
Nowak, JZ
POLISH JOURNAL OF PHARMACOLOGY, 2004, 56 (02): : 203 - 211
[35] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) inhibit IL-12 production in LPS-stimulated macrophages.
Delgado, M
Munoz-Elias, EJ
Gomariz, RP
Ganea, D
FASEB JOURNAL, 1999, 13 (04): : A320 - A320
[36] Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction
Olivia W. Miles
Victor May
Sayamwong E. Hammack
Journal of Molecular Neuroscience, 2019, 68 : 453 - 464
[37] Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction
Miles, Olivia W.
May, Victor
Hammack, Sayamwong E.
JOURNAL OF MOLECULAR NEUROSCIENCE, 2019, 68 (03) : 453 - 464
[38] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation
Zhang, Kaijun
Aruva, Mohan R.
Shanthly, Nylla
Cardi, Christopher A.
Patel, Chirag A.
Rattan, Satish
Cesarone, Gregory
Wickstrom, Eric
Thakur, Mathew L.
REGULATORY PEPTIDES, 2007, 144 (1-3) : 91 - 100
[39] The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells
Hayez, N
Harfi, I
Lema-Kisoka, R
Svoboda, M
Corazza, F
Sariban, E
JOURNAL OF NEUROIMMUNOLOGY, 2004, 149 (1-2) : 167 - 181
[40] High levels of vasoactive intestinal peptide pituitary adenylate cyclase-activating peptide receptor mRNA expression in primary and tumor lymphoid cells
Waschek, JA
Bravo, DT
Richards, ML
REGULATORY PEPTIDES, 1995, 60 (2-3) : 149 - 157

← 1 2 3 4 5 →